Jeanmarie Guenot is one of the most prominent names in the biotechnology space, and for over 20 years has been active in the biotechnology and biopharmaceutical industry. Jeanmarie has worked with many different biotech companies at all stages of development, starting from research and development to corporate and business development and from alliance management to venture capital. At present, Jeanmarie heads the Amphivena Therapeutics Inc, where she holds the position of President and CEO. Amphivena Therapeutics Inc is a firm specializing in developing highly innovative and cutting-edge antibody and cancer therapies for effective cancer diagnosis and hematologic malignancies.
Jeanmarie Guenot has experience in many different areas of the biotechnology industry, which makes her highly knowledgeable and skillful as a leader. Few of her expertise include commercial and corporate development, client management, fundraising, venture capital, business development, licensing, commercial product portfolio, research and development, and more. Jeanmarie Guenot has done Ph.D. from the University of California, San Francisco and completed her studies in business, receiving Masters in Business Administration degree from Wharton School of Business. She started her career as a principal scientist at Hoffman-La Roche on crunchbase.com, working for the firm in Basel and Shanghai, and went on to become the business advisor for the company in the following years.
Jeanmarie also founded SKS Ocular, a biotechnology research firm that focused on finding effective therapies for ocular inflammation, glaucoma, and macular degeneration. Jeanmarie was awarded the Deal of Distinction award in 2006 by Licensing Executives Society and in 2005 received Bio-Partnering Award by BioBusiness Network. Along with working for Amphivena Therapeutics Inc, Jeanmarie is also affiliated to Harpoon Therapeutics and is the co-founder of Maverick Therapeutics. Jeanmarie is also the founder of Guenot LLC, a venture capital and business consultancy firm in the biotechnology space, offering its services to numerous biopharma companies in the country.
According to linkedin.com, Jeanmarie has previous experience of working with Atlas Venture, which is another venture capital firm in biotechnology world, where she learned about the business angle of the pharmaceutical industry. Under her leadership, Amphivena Therapeutics Inc received additional funds from Janssen Biotech Inc to continue with advanced research. She continues to help the firm grow and expand with her strategic vision and exemplary leadership skills at http://amphivena.com/amphivena_leaders/jeanmarie-guenot-ph-d/.